Managing Partner, Harris Kaplan, published in Forbes: Biotech Investing - Is Hope Fueling Hype?

Harris Kaplan, Managing Partner, just published an article in Forbes, Biotech Investing: Is Hope Fueling Hype?. Hope is a major reason why people invest in biotech companies. Biotech investing offers the opportunity of financially doing well while also doing good. But hope can become hype and it is hard for average investors to sift signal from noise. Here, Harris provides one approach investors can use to determine whether the hope and hype surrounding sizzling science can actually result in successful products.